Published in Diabetes Res Clin Pract on July 14, 2014
The influence of diabetes, glycemic control, and diabetes-related comorbidities on pulmonary tuberculosis. PLoS One (2015) 1.05
Differential transcriptomic and metabolic profiles of M. africanum- and M. tuberculosis-infected patients after, but not before, drug treatment. Genes Immun (2015) 0.89
Coincident pre-diabetes is associated with dysregulated cytokine responses in pulmonary tuberculosis. PLoS One (2014) 0.86
Diabetes Mellitus and Increased Tuberculosis Susceptibility: The Role of Short-Chain Fatty Acids. J Diabetes Res (2015) 0.79
Impaired Recognition of Mycobacterium tuberculosis by Alveolar Macrophages From Diabetic Mice. J Infect Dis (2016) 0.77
Glycemic Control and the Risk of Tuberculosis: A Cohort Study. PLoS Med (2016) 0.76
Diabetes mellitus and latent tuberculosis infection: a systemic review and meta-analysis. Clin Infect Dis (2016) 0.75
Detection of latent tuberculosis infection among migrant farmworkers along the US-Mexico border. BMC Infect Dis (2016) 0.75
Association between diabetes mellitus and multi-drug-resistant tuberculosis: a protocol for a systematic review and meta-analysis. Syst Rev (2017) 0.75
Diabetes as an increasingly common comorbidity among patient hospitalizations for tuberculosis in the USA. BMJ Open Diabetes Res Care (2016) 0.75
Risk factors for pulmonary cavitation in tuberculosis patients from China. Emerg Microbes Infect (2016) 0.75
Microbiome Changes during Tuberculosis and Antituberculous Therapy. Clin Microbiol Rev (2016) 0.75
Diabetes and Tuberculosis. Microbiol Spectr (2016) 0.75
Impact of diabetes mellitus on indeterminate results of the QuantiFERON TB Gold In-Tube test: A propensity score matching analysis. PLoS One (2017) 0.75
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med (1993) 102.56
Immunology of tuberculosis. Annu Rev Immunol (2001) 14.26
Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA (2006) 11.78
Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet (1999) 10.06
Oxidative stress and diabetic complications. Circ Res (2010) 9.37
Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med (2008) 9.31
Global epidemiology of tuberculosis. Lancet (2006) 6.70
The worldwide epidemiology of type 2 diabetes mellitus--present and future perspectives. Nat Rev Endocrinol (2011) 5.55
The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med (2011) 4.91
Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med (2008) 4.25
HIV infection-associated tuberculosis: the epidemiology and the response. Clin Infect Dis (2010) 4.19
Diabetes and tuberculosis: the impact of the diabetes epidemic on tuberculosis incidence. BMC Public Health (2007) 4.13
Who puts the tubercle in tuberculosis? Nat Rev Microbiol (2006) 4.01
Vitamin D is required for IFN-gamma-mediated antimicrobial activity of human macrophages. Sci Transl Med (2011) 3.27
Tuberculosis and diabetes in southern Mexico. Diabetes Care (2004) 2.83
TNF-blocking agents and tuberculosis: new drugs illuminate an old topic. Rheumatology (Oxford) (2005) 2.69
Diabetic control and risk of tuberculosis: a cohort study. Am J Epidemiol (2008) 2.65
Progressive age-related changes in pulmonary tuberculosis images and the effect of diabetes. Am J Respir Crit Care Med (2000) 2.55
Exposure to rifampicin is strongly reduced in patients with tuberculosis and type 2 diabetes. Clin Infect Dis (2006) 2.47
Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes. Thorax (2012) 2.39
Prevalence of diabetes and pre-diabetes and associated risk factors among tuberculosis patients in India. PLoS One (2012) 2.38
Bi-directional screening for tuberculosis and diabetes: a systematic review. Trop Med Int Health (2010) 2.38
Tuberculosis in poorly controlled type 2 diabetes: altered cytokine expression in peripheral white blood cells. Clin Infect Dis (2008) 2.24
Type 2 diabetes and tuberculosis in a dynamic bi-national border population. Epidemiol Infect (2006) 2.09
Variation of chest radiographic patterns in pulmonary tuberculosis by degree of human immunodeficiency virus-related immunosuppression. The Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). The AIDS Clinical Trials Group (ACTG). Clin Infect Dis (1997) 2.07
Tuberculosis susceptibility of diabetic mice. Am J Respir Cell Mol Biol (2007) 2.03
Cross-sectional assessment reveals high diabetes prevalence among newly-diagnosed tuberculosis cases. Bull World Health Organ (2011) 1.95
Pulmonary tuberculosis in patients with diabetes mellitus. Respiration (2001) 1.86
Risk of tuberculosis among people with diabetes mellitus: an Australian nationwide cohort study. BMJ Open (2012) 1.85
Beyond hemoglobin A1c--need for additional markers of risk for diabetic microvascular complications. JAMA (2010) 1.69
Lower expression of Th1-related cytokines and inducible nitric oxide synthase in mice with streptozotocin-induced diabetes mellitus infected with Mycobacterium tuberculosis. Clin Exp Immunol (2005) 1.64
Pulmonary complications of diabetes mellitus. Pneumonia. Infect Dis Clin North Am (1995) 1.58
Estimates of the impact of diabetes on the incidence of pulmonary tuberculosis in different ethnic groups in England. Thorax (2010) 1.52
Diabetic mice display a delayed adaptive immune response to Mycobacterium tuberculosis. J Immunol (2010) 1.48
Tuberculosis among diabetics: the Philadelphia survey. Am Rev Tuberc (1952) 1.46
Diabetes and immunity to tuberculosis. Eur J Immunol (2014) 1.45
Type 2 diabetes and multidrug-resistant tuberculosis. Scand J Infect Dis (2008) 1.40
Pharmacokinetics of antituberculosis drugs in pulmonary tuberculosis patients with type 2 diabetes. Antimicrob Agents Chemother (2009) 1.36
Impact of diabetes and smoking on mortality in tuberculosis. PLoS One (2013) 1.36
Expansion of pathogen-specific T-helper 1 and T-helper 17 cells in pulmonary tuberculosis with coincident type 2 diabetes mellitus. J Infect Dis (2013) 1.36
Site of extrapulmonary tuberculosis is associated with HIV infection. Clin Infect Dis (2012) 1.34
Role of QuantiFERON-TB gold, interferon gamma inducible protein-10 and tuberculin skin test in active tuberculosis diagnosis. PLoS One (2010) 1.34
Questionable role of interferon-γ assays for smear-negative pulmonary TB in immunocompromised patients. J Infect (2011) 1.33
The risk of tuberculosis disease among persons with diabetes mellitus: a prospective cohort study. Clin Infect Dis (2012) 1.22
Hypodense alveolar macrophages in patients with diabetes mellitus and active pulmonary tuberculosis. Tuber Lung Dis (1999) 1.21
Consultation meeting on tuberculosis and diabetes mellitus: meeting summary and recommendations. Int J Tuberc Lung Dis (2010) 1.21
Modeling the Mycobacterium tuberculosis Granuloma - the Critical Battlefield in Host Immunity and Disease. Front Immunol (2013) 1.21
Risk factors for extra-pulmonary tuberculosis compared to pulmonary tuberculosis. Int J Tuberc Lung Dis (2009) 1.19
Diabetes, glycemic control, and risk of tuberculosis: a population-based case-control study. Diabetes Care (2011) 1.11
Reduced Mycobacterium tuberculosis association with monocytes from diabetes patients that have poor glucose control. Tuberculosis (Edinb) (2012) 1.10
Host-pathogen interactions in tuberculosis patients with type 2 diabetes mellitus. Tuberculosis (Edinb) (2013) 1.07
Sputum induction to aid diagnosis of smear-negative or sputum-scarce tuberculosis in adults in HIV-endemic settings. Eur Respir J (2013) 1.05
Macrophages in tuberculosis: friend or foe. Semin Immunopathol (2013) 1.04
Effect of age on presentation with diabetes: Comparison of nondiabetic patients with new smear-positive pulmonary tuberculosis patients. Lung India (2011) 1.03
The effect of glucose variability on the risk of microvascular complications in type 1 diabetes. Diabetes Care (2007) 1.03
Effect of diabetes on treatment outcome of smear-positive pulmonary tuberculosis--a report from South India. J Diabetes Complications (2013) 0.96
The sensitivity of interferon-gamma release assays is not compromised in tuberculosis patients with diabetes. Int J Tuberc Lung Dis (2011) 0.95
Glycemic control and radiographic manifestations of tuberculosis in diabetic patients. PLoS One (2014) 0.94
Early and late tuberculosis risks among close contacts in Hong Kong. Int J Tuberc Lung Dis (2008) 0.94
Phagocytosis via complement or Fc-gamma receptors is compromised in monocytes from type 2 diabetes patients with chronic hyperglycemia. PLoS One (2014) 0.93
Socio-demographic and clinical differences in subjects with tuberculosis with and without diabetes mellitus in Brazil--a multivariate analysis. PLoS One (2013) 0.92
Pharmacokinetics of rifampin in Peruvian tuberculosis patients with and without comorbid diabetes or HIV. Antimicrob Agents Chemother (2012) 0.92
The effect of glucose variability on the risk of microvascular complications in type 1 diabetes. Diabetes Care (2007) 0.92
Managing tuberculosis in patients with diabetes mellitus: why we care and what we know. Expert Rev Anti Infect Ther (2012) 0.91
Plasma concentrations of isoniazid and rifampin are decreased in adult pulmonary tuberculosis patients with diabetes mellitus. Antimicrob Agents Chemother (2013) 0.91
Diabetes is associated with lower tuberculosis antigen-specific interferon gamma release in Tanzanian tuberculosis patients and non-tuberculosis controls. Scand J Infect Dis (2014) 0.88
Epidemiology of tuberculosis immunology. Adv Exp Med Biol (2013) 0.87
Is alcohol use associated with cavitary disease in tuberculosis? Alcohol Clin Exp Res (2007) 0.87
Immunology of tuberculosis. Swiss Med Wkly (2007) 0.81
Significance of the frequency of CD4+CD25+CD127- T-cells in patients with pulmonary tuberculosis and diabetes mellitus. Respirology (2012) 0.81
Is there an effect of glucose lowering treatment on incidence and prognosis of tuberculosis? A systematic review. Curr Diab Rep (2014) 0.77
The dynamics of tuberculosis epidemiology. Indian J Tuberc (2014) 0.77